Adverse drug reactions at a university hospital in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFBA |
Texto Completo: | http://repositorio.ufba.br/ri/handle/ri/22710 |
Resumo: | Abstract The aim of this study is to characterize the patients and the ADR notified to a Pharmacovigilance Center at a university hospital in Brazil. The ADR rate in hospitalized patients is 10% to 20% and the frequency of hospitalization due to ADR is 0,5% to 6,5%. The ADRs contribute to the increase of length in hospitalization and costs. Patient’s exposures have an increase in the rate of mortality, although about 60% to 80% could be prevented. A descriptive study carried at a university hospital in Northeast of Brazil, where all the spontaneous notifications were analyzed during two years. For the process of notification of ADR suspicions, WHO definition was used. After receiving the notification, ADR suspicions were analyzed and the causality assessment was done by CFV staff members, using three different algorithms, and classified according to severity and type. Seventy eight ADR suspicions were spontaneously notified. The female gender represented 55% of cases. Black and mulatto races represented 70%. The most frequent organ and system affected was the skin. Medicines most frequently involved in ADR were anti-infectious agents followed by anti-parasitic agents. The causality assessment shows that the frequency of certain and probable ADRs were around 55%. ADRs severity was moderate in 41%, although more than 60% of all ADRs could be prevented. ADRs are a major problem and measures must be adopted to minimize them. |
id |
UFBA-2_d72a06c5a91c9fe1ff946d8ee64b6b90 |
---|---|
oai_identifier_str |
oai:repositorio.ufba.br:ri/22710 |
network_acronym_str |
UFBA-2 |
network_name_str |
Repositório Institucional da UFBA |
repository_id_str |
1932 |
spelling |
Toledo, L. A. Kister deNoblat, L.Noblat, A.C.B.Oliveira, M.G.Santos, P.M.Toledo, L. A. Kister deNoblat, L.Noblat, A.C.B.Oliveira, M.G.Santos, P.M.2017-06-01T19:33:56Z2017-06-01T19:33:56Z2010R. Ci. méd. biol., v. 9, Supl.1, p. 40-45, 2010.1677-5090http://repositorio.ufba.br/ri/handle/ri/22710v.9, n.1Abstract The aim of this study is to characterize the patients and the ADR notified to a Pharmacovigilance Center at a university hospital in Brazil. The ADR rate in hospitalized patients is 10% to 20% and the frequency of hospitalization due to ADR is 0,5% to 6,5%. The ADRs contribute to the increase of length in hospitalization and costs. Patient’s exposures have an increase in the rate of mortality, although about 60% to 80% could be prevented. A descriptive study carried at a university hospital in Northeast of Brazil, where all the spontaneous notifications were analyzed during two years. For the process of notification of ADR suspicions, WHO definition was used. After receiving the notification, ADR suspicions were analyzed and the causality assessment was done by CFV staff members, using three different algorithms, and classified according to severity and type. Seventy eight ADR suspicions were spontaneously notified. The female gender represented 55% of cases. Black and mulatto races represented 70%. The most frequent organ and system affected was the skin. Medicines most frequently involved in ADR were anti-infectious agents followed by anti-parasitic agents. The causality assessment shows that the frequency of certain and probable ADRs were around 55%. ADRs severity was moderate in 41%, although more than 60% of all ADRs could be prevented. ADRs are a major problem and measures must be adopted to minimize them.Submitted by ROBERTO PAULO CORREIA DE ARAÚJO (ppgorgsistem@ufba.br) on 2017-06-01T19:33:56Z No. of bitstreams: 1 8_v.9_1.pdf: 111976 bytes, checksum: 1f1f97e4d640493b3d52bdf21f06581b (MD5)Made available in DSpace on 2017-06-01T19:33:56Z (GMT). No. of bitstreams: 1 8_v.9_1.pdf: 111976 bytes, checksum: 1f1f97e4d640493b3d52bdf21f06581b (MD5) Previous issue date: 2010-01SalvadorInstituto de Ciências da Saúde/ Universidade Federal da BahiaBrasilhttp://www.portalseer.ufba.br/index.php/cmbio/article/view/4639/3473reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAFarmacovigilância/Reações adversasMedicamentos /Efeitos dversosAdverse drug reactions at a university hospital in BrazilRevista de Ciências Médicas e Biológicasinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessporORIGINAL8_v.9_1.pdf8_v.9_1.pdfapplication/pdf111976https://repositorio.ufba.br/bitstream/ri/22710/1/8_v.9_1.pdf1f1f97e4d640493b3d52bdf21f06581bMD51LICENSElicense.txtlicense.txttext/plain1383https://repositorio.ufba.br/bitstream/ri/22710/2/license.txt05eca2f01d0b3307819d0369dab18a34MD52TEXT8_v.9_1.pdf.txt8_v.9_1.pdf.txtExtracted texttext/plain25265https://repositorio.ufba.br/bitstream/ri/22710/3/8_v.9_1.pdf.txt99a5341350961932681a45fdc8fcc024MD53ri/227102022-11-03 14:32:40.54oai:repositorio.ufba.br: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ório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-11-03T17:32:40Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false |
dc.title.pt_BR.fl_str_mv |
Adverse drug reactions at a university hospital in Brazil |
dc.title.alternative.pt_BR.fl_str_mv |
Revista de Ciências Médicas e Biológicas |
title |
Adverse drug reactions at a university hospital in Brazil |
spellingShingle |
Adverse drug reactions at a university hospital in Brazil Toledo, L. A. Kister de Farmacovigilância/Reações adversas Medicamentos /Efeitos dversos |
title_short |
Adverse drug reactions at a university hospital in Brazil |
title_full |
Adverse drug reactions at a university hospital in Brazil |
title_fullStr |
Adverse drug reactions at a university hospital in Brazil |
title_full_unstemmed |
Adverse drug reactions at a university hospital in Brazil |
title_sort |
Adverse drug reactions at a university hospital in Brazil |
author |
Toledo, L. A. Kister de |
author_facet |
Toledo, L. A. Kister de Noblat, L. Noblat, A.C.B. Oliveira, M.G. Santos, P.M. |
author_role |
author |
author2 |
Noblat, L. Noblat, A.C.B. Oliveira, M.G. Santos, P.M. |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Toledo, L. A. Kister de Noblat, L. Noblat, A.C.B. Oliveira, M.G. Santos, P.M. Toledo, L. A. Kister de Noblat, L. Noblat, A.C.B. Oliveira, M.G. Santos, P.M. |
dc.subject.por.fl_str_mv |
Farmacovigilância/Reações adversas Medicamentos /Efeitos dversos |
topic |
Farmacovigilância/Reações adversas Medicamentos /Efeitos dversos |
description |
Abstract The aim of this study is to characterize the patients and the ADR notified to a Pharmacovigilance Center at a university hospital in Brazil. The ADR rate in hospitalized patients is 10% to 20% and the frequency of hospitalization due to ADR is 0,5% to 6,5%. The ADRs contribute to the increase of length in hospitalization and costs. Patient’s exposures have an increase in the rate of mortality, although about 60% to 80% could be prevented. A descriptive study carried at a university hospital in Northeast of Brazil, where all the spontaneous notifications were analyzed during two years. For the process of notification of ADR suspicions, WHO definition was used. After receiving the notification, ADR suspicions were analyzed and the causality assessment was done by CFV staff members, using three different algorithms, and classified according to severity and type. Seventy eight ADR suspicions were spontaneously notified. The female gender represented 55% of cases. Black and mulatto races represented 70%. The most frequent organ and system affected was the skin. Medicines most frequently involved in ADR were anti-infectious agents followed by anti-parasitic agents. The causality assessment shows that the frequency of certain and probable ADRs were around 55%. ADRs severity was moderate in 41%, although more than 60% of all ADRs could be prevented. ADRs are a major problem and measures must be adopted to minimize them. |
publishDate |
2010 |
dc.date.issued.fl_str_mv |
2010 |
dc.date.accessioned.fl_str_mv |
2017-06-01T19:33:56Z |
dc.date.available.fl_str_mv |
2017-06-01T19:33:56Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
R. Ci. méd. biol., v. 9, Supl.1, p. 40-45, 2010. |
dc.identifier.uri.fl_str_mv |
http://repositorio.ufba.br/ri/handle/ri/22710 |
dc.identifier.issn.none.fl_str_mv |
1677-5090 |
dc.identifier.number.pt_BR.fl_str_mv |
v.9, n.1 |
identifier_str_mv |
R. Ci. méd. biol., v. 9, Supl.1, p. 40-45, 2010. 1677-5090 v.9, n.1 |
url |
http://repositorio.ufba.br/ri/handle/ri/22710 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Instituto de Ciências da Saúde/ Universidade Federal da Bahia |
dc.publisher.country.fl_str_mv |
Brasil |
publisher.none.fl_str_mv |
Instituto de Ciências da Saúde/ Universidade Federal da Bahia |
dc.source.pt_BR.fl_str_mv |
http://www.portalseer.ufba.br/index.php/cmbio/article/view/4639/3473 |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFBA instname:Universidade Federal da Bahia (UFBA) instacron:UFBA |
instname_str |
Universidade Federal da Bahia (UFBA) |
instacron_str |
UFBA |
institution |
UFBA |
reponame_str |
Repositório Institucional da UFBA |
collection |
Repositório Institucional da UFBA |
bitstream.url.fl_str_mv |
https://repositorio.ufba.br/bitstream/ri/22710/1/8_v.9_1.pdf https://repositorio.ufba.br/bitstream/ri/22710/2/license.txt https://repositorio.ufba.br/bitstream/ri/22710/3/8_v.9_1.pdf.txt |
bitstream.checksum.fl_str_mv |
1f1f97e4d640493b3d52bdf21f06581b 05eca2f01d0b3307819d0369dab18a34 99a5341350961932681a45fdc8fcc024 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA) |
repository.mail.fl_str_mv |
|
_version_ |
1808459509692104704 |